From Risk to Action: Predictive Profiling and Contemporary Treatment Context in Rheumatoid Arthritis Mortality
Year: 2026
Type: article
Abstract: We were intrigued by the recent article by Joerns et al1 that drew 4 decades of data from the Rochester Epidemiology Project (REP) to demonstrate a more than 2-fold increase in respiratory-related mortality among seropositive patients with rheumatoid arthritis (RA) compared with non-RA controls—a risk not observed in seronegative RA. This finding solidifies serostatus as a critical prognostic marker. To help translate this epidemiological insight into clinical practice, we wish to propose 3 methodological and interpretive refinements.
Source: The Journal of Rheumatology
Authors: Zhen Wang, Jiasi Zheng, Wu-Kai Ma
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funder: National Institutes of Health
OpenAlex ID: W7146964875
FWCI:
Cites:
Cited by:
Related to:
